drugset / Trial / NCT00189332
Use of 852A in Metastatic Cutaneous Melanoma.
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Pilot study to test the efficacy of 852A administered intravenously up to 3 times per week for 12 weeks in subjects with inoperable metastatic cutaneous melanoma.
Timeline
- Start
- 2005-02
- Primary completion
- 2006-08
- Completion
- 2006-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CPG-52852 | Small molecule | — | Intravenous |